CAR-T Cell Therapy Targets
Chimeric antigen receptor (CAR) T-cell therapy is a kind of cancer treatment that uses cells from your own immune system. Doctors take a type of white blood cell from your body and genetically change the cells in a lab so they can better find your cancer. Then millions of these target-seeking cells are put back into your body. CAR-T Cell Therapy Targets refer to targets involved in CAR-T cell therapy. More information about CAR-T Cell Therapy, you can click the following link: https://www.cusabio.com/car-t-cell-therapy.html.
CUSABIO has successfully developed over several active proteins, covering the hottest investigational CAR-T cell therapy targets. All of these proteins with high purity and high binding activity. Therefore, CAR-T cell therapy target proteins in CUSABIO are the first choice for your scientific research.
Regard reading: CAR-T Cell Therapy- An Useful Treatment To Cancer.
Highly Identical Protein Sequences
Based on the SEQUEST from database of Mammalian Cell host and target protein, the LC-MS/MS Analysis result of CSB-MP007479HU could indicate that this peptide derived from Mammalian Cell-expressed Recombinant Human EGFR.
CUSABIO: EC50=1.404-1.905 ng/ml
XX company: EC50=1.720-2.184 ng/ml